Noninvasive Detection of Atrial Fibrillation in Cryptogenic Stroke: Contribution of a New E-cardiology Device
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Hart R, Diener H, Coutts S, Easton J, Granger C, ODonnell M
. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014; 13(4):429-38.
DOI: 10.1016/S1474-4422(13)70310-7.
View
2.
Slotwiner D, Varma N, Akar J, Annas G, Beardsall M, Fogel R
. HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices. Heart Rhythm. 2015; 12(7):e69-100.
DOI: 10.1016/j.hrthm.2015.05.008.
View
3.
Reiffel J
. Atrial fibrillation and stroke: epidemiology. Am J Med. 2014; 127(4):e15-6.
DOI: 10.1016/j.amjmed.2013.06.002.
View
4.
Guedon-Moreau L, Lacroix D, Sadoul N, Clementy J, Kouakam C, Hermida J
. A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial. Eur Heart J. 2012; 34(8):605-14.
PMC: 3578267.
DOI: 10.1093/eurheartj/ehs425.
View
5.
Lip G, Nieuwlaat R, Pisters R, Lane D, Crijns H
. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2009; 137(2):263-72.
DOI: 10.1378/chest.09-1584.
View